$SLQT

SelectQuote receives NYSE notice over stock price compliance

SelectQuote Inc. (NYSE: SLQT) received a notice from the NYSE due to its common stock trading below $1.00 per share for 30 consecutive trading days. The company has a six-month cure period to regain compliance, needing its stock to close at or above $1.00 with an average closing price of at least $1.00 over the preceding 30 days. Despite the current low stock price and the delisting notice, InvestingPro analysis suggests the stock may be undervalued, and the company recently reported stronger-than-expected Q2 fiscal year 2026 earnings and launched a new franchise model.

Original reporting
Investing.com · Company News
Published Mar 26, 2026, 1:39 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 26, 2026, 2:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$SLQT
Neutral
medium confidence
Mentioned
$SLQT
alphai data visualization · based on Investing.com
Decision brief

The 30-second read

$SLQTNeutralMed
01

Why it matters

The delisting notice introduces short-term volatility and potential downside risk. However, positive earnings and strategic moves could support a future rebound, especially if the company addresses compliance issues.

02

Market read

The news is highly relevant for traders holding or considering trading SLQT, with implications for short-term trading strategies and long-term investment considerations.

03

What to watch

Possible regulatory changes or market sentiment shifts that could influence delisting outcomes and stock recovery.

Timing: Immediate to short-term; news published today.

Background

SelectQuote's stock has been trading below $1.00 for over 30 days, triggering NYSE delisting procedures. Despite this, the company reported strong Q2 earnings and is launching new franchise models, which may signal underlying operational strength.

Company-level read

Ticker impact

$SLQTNeutralMedium confidence
Context

Primary focus due to NYSE delisting notice and recent earnings report.

Expected impact

Potential short-term decline due to delisting concerns; possible rebound if company actions restore compliance and investor confidence.

Evidence & confidence

While the delisting risk introduces downside pressure, recent positive earnings and strategic initiatives could lead to a valuation correction. The mixed signals warrant cautious positioning.

Market effects

Potential negative sentiment in the financial services sector due to delisting concerns.

Limited; primarily affects NYSE-listed companies and investors.

Low; specific to US markets and the company's operations.

Counterpoint

The company's recent earnings and strategic initiatives could lead to a recovery in stock price, making current low levels a potential buying opportunity for long-term investors.

Key entities

  • SelectQuote Inc.

    A provider of insurance distribution services, listed on NYSE.

  • NYSE

    New York Stock Exchange, which has issued a delisting notice to SLQT.

Related articles

$SLQTHighAI 8/10

Why is Selectquote stock sliding today?

Selectquote (SLQT) shares dropped 16.59% in pre-market trading to $0.643 after missing Q4 2026 earnings and revenue estimates. The company reported a loss of $0.19 per share and $321.7M in revenue, while FY2027 guidance of $1.35B-$1.45B fell below consensus. Analysts had already lowered ratings due to sector headwinds, including Medicare Advantage marketing cuts and reimbursement pressures.

$RBAHigh

Why This U.S. Auto Retail Stock is Barclays’ Top Pick Right Now

Barclays named RB Global Inc (RBA) its top U.S. auto retail pick, citing an attractive valuation at 12.7x EV/EBITDA, market share gains, and cyclical improvements in its Heavy Equipment & Transportation segment. RBA reported Q2 2026 revenue of $1.32B, beating estimates, with 11% gross transaction value growth. Barclays expects RBA to gain market share from Copart Inc (CPRT) in the salvage vehicle auction market.

$GHHighAI 8/10

Guardant ordered to pay $245m in DNA sequencing patent dispute

Guardant Health was ordered to pay $245.2m to TwinStrand Biosciences and the University of Washington for patent infringement. The ruling covers 11 products, including Guardant360 CDx, and includes damages, royalties, and interest. Guardant plans to appeal, while TwinStrand affirms its commitment to its intellectual property.

$KURAMed

Why is Kura Oncology stock surging today?

Kura Oncology's stock rose 11.6% in pre-market trading after CEO Troy Wilson bought 100,000 shares for $1.24 million, his second large purchase in a week. Analysts Citigroup and Jefferies reaffirmed positive ratings, citing strong commercial momentum for KOMZIFTI and Q2 earnings beat. The stock surpassed its 52-week high of $12.90.

$BEMed

Nancy Pelosi Made Millions On Nvidia Options. Now She’s Betting $3 Million On 1 AI Energy Stock

Paul Pelosi, spouse of House Speaker Nancy Pelosi, acquired 15,000 shares and 200 call options of Bloom Energy (BE) in July 2026, with a potential investment ranging from $3 million to $12 million. Bloom Energy reported Q2 2026 revenue of $1.065 billion, up 165.5% year-over-year, and raised full-year guidance to $3.9 billion to $4.2 billion. The stock closed at $204.02 on August 24, 2026, up 134.8% year-to-date. The Pelosi household also added to an existing Intel (INTC) position.